Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8911732 Anti-mesothelin antibodies and immunoconjugates

Patent 8911732 was granted and assigned to Genentech on December, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Genentech
Genentech
Date Filed
December 19, 2011
Date of Patent
December 16, 2014
Patent Application Number
13330414
Patent Citations Received
‌
US Patent 11851491 Compositions and methods for TCR reprogramming using fusion proteins
0
‌
US Patent 11965012 Compositions and methods for TCR reprogramming using fusion proteins
0
‌
US Patent 11884720 Antibody constructs for MSLN and CD3
0
‌
US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
0
‌
US Patent 11981745 Anti-mesothelin antigen-binding molecules and uses thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8911732
Patent Primary Examiner
‌
Brian J Gangle

Find more entities like US Patent 8911732 Anti-mesothelin antibodies and immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.